Skip to main content
Recall Canary
LVIS Intraluminal Support Device
← Back to all recalls
MEDICAL DEVICE RECALLMODERATE

LVIS Intraluminal Support Device

MicroVention recalls LVIS Intraluminal Support Devices (REF 214022-CAS, 214518-CAS, 213517-CAS) due to dimensional nonconformance risking vessel injury or thrombosis.

What to do

If you have received this device, contact MicroVention immediately to verify whether your device is affected and to discuss appropriate next steps, which may include device replacement or retrieval.

Recalled
Listed
Updated
Recall No.
Z-2200-2026
Agency
FDA
Firm
MICROVENTION INC.
Recall ID
98755
Status
ONGOING

Why it was recalled

MicroVention is recalling LVIS Intraluminal Support Devices (REF 214022-CAS, 214518-CAS, 213517-CAS) due to dimensional nonconformance and incorrect device configuration that may result from manufacturing commingling. Oversized devices may cause increased vessel wall stress, neointimal hyperplasia, or vessel injury/rupture; undersized devices may lead to incomplete expansion, malposition, acute stent thrombosis, distal embolization, or ischemic neurological events.

Is mine affected?

Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.

LVIS Intraluminal Support Device, REF/Outside Diameter(OD)xTotal Length(TL)xWorking Length(WL): 214022-CAS/4.0 mm x 22 mm x 18 mm, 214518-CAS/4.5 mm x 18 mm x 14 mm, 213517-CAS/3.5 mm x 17 mm x 13 mm

Lot code
0000616462, 0000619851, 0000552987, 0000551725
UDI-DI
0000616462, 0000619851, 0000552987, 0000551725, 00842429115893, 0000552987, 00842429115893, 0000552987, 00842429115893, 0000552987, 00842429115930, 0000551725, 00842429115930, 0000551725, 00842429115930, 0000616462, 00842429115930, 0000616462, 00842429115961, 0000619851

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other recent recalls from MICROVENTION INC.

All recalls from MICROVENTION INC.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-05-15 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification